Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis-Reference-Cited by-同舟云学术

Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis

Published:2023-11-27 Issue:2 Volume:55 Page:
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Liu Yingyue¹,Chu Yurou¹,Liu Jiarui²,Ge Xueling²,Ding Mei²,Li Peipei²,Liu Fang³,Zhou Xiangxiang²⁴⁵,Wang Xin¹²⁴⁵

Affiliation:

1. Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China

2. Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

3. Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

4. Branch of National Clinical Research Center for Hematologic Diseases, Jinan, Shandong, China

5. National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Suzhou, China

Funder

National Natural Science Foundation

Key Research and Development Program of Shandong Province

China Postdoctoral Science Foundation

Translational Research Grant of NCRCH

Shandong Provincial Natural Science Foundation

Taishan Scholars Program of Shandong Province

Shandong Provincial Engineering Research Center of Lymphoma

Academic Promotion Programme of Shandong First Medical University

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2023.2282652

Reference28 articles.

1. Non-Hodgkin lymphoma

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Novel and emerging therapies for B cell lymphoma

4. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors

5. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia